Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...

Danaher (NYSE:DHR) stock merits your attention. Why? Because it offers monopoly-like high margins at a discounted price. Here are some details.BERLIN, GERMANY - SEPTEMBER 05: A doctor speaks to a patient as a sphygmomanometer, or blood pressure meter, lies on his desk on September 5, 2012 in Berlin, Germany. Doctors in the country are demanding higher payments from health insurance companies (Krankenkassen). Over 20 doctors' associations are expected to hold a vote this week over possible strikes and tempor ...

 Management and HMS Consulting Geologist Complete Site Visits to Crackingstone, AJ, and CBC Properties Vancouver, B.C., October 15, 2025 – TheNewswire – Belmont Resources Inc. (TSX-V: BEA; FSE: L3L2) (“Belmont” or the “Company”) is pleased to announce the commencement of a comprehensive core relogging and resampling program at its flagship Crackingstone Uranium Project near Uranium City, Saskatchewan. The program marks the next stage in advancing Belmont’s exploration efforts within the uranium- and rare-e ...

Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve many of the world’s most important health challenges. It focuses on areas such as Life Sciences, Diagnostics, Biotechnology, and more. Valued at $145 billion by market cap, Danaher employs thousands of people and operates in 50+ countries and 700 different locations across the globe. The healthcare giant is gearing up to announce its third-quarter results before the market opens on Tue ...

当"内卷"成为商业常态，中国企业如何破局重生？ 2025年的商业世界正经历前所未有的重构：同质化竞争吞噬利润，价格战挤压生存空间，成本攀升与 增长乏力成为企业共同的焦虑。当"降本增效"从战略选择变为生存刚需，当并购整合的失败率居高不 下，中国企业亟需一套穿越周期的系统性方法论。 《丹纳赫模式》这部由丹纳赫中国区前高管撰写的著作，首次从专家视角完整拆解全球"并购之王"丹 纳赫的制胜之道——以DBS（丹纳赫商业系统）为引擎，将精益管理从工具进化为基因，用400次并 购鲜有败绩的实战，验证了：伟大的企业之所以伟大，就在于把常识做到了极致。 以下为美的集团董事长方洪波为《丹纳赫模式》撰写的推荐序 中国企业穿越周期的行动纲领 美的基于精益管理理念，参考DBS建设了自己的MBS。同时，美的深入推进全面数字化，在DBS的基础上 更进一步，将精益管理与数字化完美融合。中国有着世界一流的数字化生态，中国企业没有沉重的历史负 担，因此能直接将最先进的数字化、智能化与管理体系打通。未来的效率竞争，既是精益管理能力的竞 争，也是数据密度与算法精度的较量。 丹纳赫集团的全球化策略并非简单的资产并购，而是内生与外延的双轮驱动再加上"技术 ...

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks were selling off to close the week after President Donald Trump threatened a "massive" tariff increase on China amid a dispute over rare earth minerals. Over the summer, Trump cautioned that he would place steeper tariffs on China if it curbed exports of rare earth magnets. This announcement, however, still surprised the m ...

| 关键财务指标 | | | 1991—2000 2001—2010 2011—2020 2021—2024 | | | --- | --- | --- | --- | --- | | 企业价值与营业 收入比 | 1.8 | 2.4 | 3.3 | 7.5 | | 企业价值倍数 | 11.5 | 13.0 | 14.3 | 22.4 | | 市盈率(倍) | 26.5 | 23.5 | 23.6 | 36.8 | | 毛利率(%) | 32.0 | 43.0 | 54.0 | 60.0 | | 息税前利润率(%) | 11.0 | 15.0 | 17.0 | 搜狐写句单仁行 | 在2024年《财富》世界500强榜单，美的集团位列第246位，而丹纳赫集团排名第161位。 在30多年时间中，丹纳赫保持了持续的增长，毛利率净利率翻倍，连续30年自由现金流超过净利润，每股收益平均每年实现两位数的增长，年均复合股东 回报率高达22%。 如果不是深入研究美的公司的商业系统MBS，我可能就错过了美的学习对象，美国丹纳赫这家公司。 这样的表现不仅远超其他多元化集团通用电气、霍尼韦尔和3M等，也超过了股神巴菲特执掌的伯克希尔。 ...

Core Thesis - Danaher Corporation is viewed positively due to its strong positioning in the biotech and diagnostics sectors, supported by its disciplined transformation and strategic acquisitions [1][3][5] Company Overview - Danaher Corporation's share price was $185.91 as of September 24th, with trailing and forward P/E ratios of 39.47 and 21.69 respectively [1] - The company has evolved from industrial tools to life sciences, diagnostics, and bioprocessing, demonstrating a history of strategic spin-offs to focus on high-growth segments [3] Market Position - Danaher is a key player in the biotech and diagnostics sectors, with significant acquisitions like Pall and Cytiva enhancing its role as a supplier for biologics, cell therapy, and vaccine production [2][4] - The company offers a vertically integrated bioprocessing platform that supports biotech firms from research to full-scale manufacturing, benefiting from recurring revenue and high switching costs [4] Financial Performance - The pandemic initially boosted demand for Danaher's products, but excess inventories by biopharma customers have since pressured margins and slowed order flow [2] - Despite a 5.4% decline in stock price due to inventory overhangs, the company's fundamentals remain resilient, and it is considered a high-quality compounder [6] Competitive Advantage - Danaher's competitive edge lies in the disciplined application of the Danaher Business System, management alignment, and its ability to adapt, which positions it for sustained growth in critical biotech infrastructure and diagnostics markets [5]

丹纳赫集团是世界范围内近40年并购最为成功的产业公司，它的出手次数、规模和业绩回报甚至可以比肩以企业并购为核心业务的私募巨擘黑石和 KKR。在丹纳 赫集团40多年的发展过程中，总计完成了近 400 次并购，花费约900亿美元，配合DBS赋能的超一流经营能力，创造出了市值约 2000 亿美元的丹纳赫集团以及一 众经由丹纳赫集团分拆、出售而成的其他上市企业，如福迪威、盈纬达、Vontier、Veralto 等。如果将其分拆和出售公司算在内，丹纳赫集团为股东创造了约 2500 亿美元的价值。 凭借着战略并购和 DBS 运营的双轮驱动，丹纳赫集团的股价在过去 40 年达到了年均 22% 的回报率，不仅远超标普 500 指数年均 12% 的表现，更是压过巴菲特执 掌的伯克希尔 - 哈撒韦同期 16% 的股东回报率。这个股东回报率与同期的苹果公司几乎相当。 那么，这样一家巨无霸企业究竟是如何通过并购建成的？丹纳赫集团在不同时期的并购风格和价值创造模式分别是什么？并购背后的流程和团队是如何演化的？ 由丹纳赫中国区前高管杨益、陈朝巍合著的《丹纳赫模式》一书，首次系统拆解丹纳赫集团并购整合的核心能力，揭示"并购之王"究竟是如何 ...

READING BOOKS 「 湛庐·十一特辑 」 2025年的商业竞争中，市场从增量竞争转向存量厮杀，传统的"风口套利"模式日渐失效，依靠单一业务增长似乎总能看到天花板。而丹纳赫，这个曾经将 数百家企业整合、优化，最终孵化出市值超千亿美元的巨头却依然在持续创造价值。 当下的经济环境，正呼唤丹纳赫式的商业智慧！ ▲ 点击书封，立即入手 以丹纳赫为镜，锻造企业韧性 ——《丹纳赫模式》推荐序 美的集团董事长兼总裁方洪波先生，在这篇极具实践洞察的推荐序中，他深刻指出，伟大的企业皆因将"常识做到极致"——坚守流程、尊重事实、效率至 上。 请阅读本书，为大脑充电、为未来布局，这是一部能重塑你商业思维体系的深度之作。 无论是寻求转型升级的企业创始人、致力于推动内部变革的高管，还是希望在价值投资中精益求精的投资人，都能从中获得至关重要的启示！ 文/方洪波 美的集团董事长兼总裁 丹纳赫集团用40多年的时间，从美国本土低端制造业的杠杆并购者，进化为全球生命科学领域的冠军企业。丹纳赫商业系统(DanaherBusiness System,DBS) 的精髓是"常识为纲，贯彻有方(Commonsense,vigorously app ...